Cargando…

Cdc25 and Wee1: analogous opposites?

Movement through the cell cycle is controlled by the temporally and spatially ordered activation of cyclin-dependent kinases paired with their respective cyclin binding partners. Cell cycle events occur in a stepwise fashion and are monitored by molecular surveillance systems to ensure that each cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Perry, Jennifer A, Kornbluth, Sally
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868713/
https://www.ncbi.nlm.nih.gov/pubmed/17480229
http://dx.doi.org/10.1186/1747-1028-2-12
_version_ 1782133387614486528
author Perry, Jennifer A
Kornbluth, Sally
author_facet Perry, Jennifer A
Kornbluth, Sally
author_sort Perry, Jennifer A
collection PubMed
description Movement through the cell cycle is controlled by the temporally and spatially ordered activation of cyclin-dependent kinases paired with their respective cyclin binding partners. Cell cycle events occur in a stepwise fashion and are monitored by molecular surveillance systems to ensure that each cell cycle process is appropriately completed before subsequent events are initiated. Cells prevent entry into mitosis while DNA replication is ongoing, or if DNA is damaged, via checkpoint mechanisms that inhibit the activators and activate the inhibitors of mitosis, Cdc25 and Wee1, respectively. Once DNA replication has been faithfully completed, Cdc2/Cyclin B is swiftly activated for a timely transition from interphase into mitosis. This sharp transition is propagated through both positive and negative feedback loops that impinge upon Cdc25 and Wee1 to ensure that Cdc2/Cyclin B is fully activated. Recent reports from a number of laboratories have revealed a remarkably complex network of kinases and phosphatases that coordinately control Cdc25 and Wee1, thereby precisely regulating the transition into mitosis. Although not all factors that inhibit Cdc25 have been shown to activate Wee1 and vice versa, a number of regulatory modules are clearly shared in common. Thus, studies on either the Cdc25 or Wee1-regulatory arm of the mitotic control pathway should continue to shed light on how both arms are coordinated to smoothly regulate mitotic entry.
format Text
id pubmed-1868713
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18687132007-05-15 Cdc25 and Wee1: analogous opposites? Perry, Jennifer A Kornbluth, Sally Cell Div Review Movement through the cell cycle is controlled by the temporally and spatially ordered activation of cyclin-dependent kinases paired with their respective cyclin binding partners. Cell cycle events occur in a stepwise fashion and are monitored by molecular surveillance systems to ensure that each cell cycle process is appropriately completed before subsequent events are initiated. Cells prevent entry into mitosis while DNA replication is ongoing, or if DNA is damaged, via checkpoint mechanisms that inhibit the activators and activate the inhibitors of mitosis, Cdc25 and Wee1, respectively. Once DNA replication has been faithfully completed, Cdc2/Cyclin B is swiftly activated for a timely transition from interphase into mitosis. This sharp transition is propagated through both positive and negative feedback loops that impinge upon Cdc25 and Wee1 to ensure that Cdc2/Cyclin B is fully activated. Recent reports from a number of laboratories have revealed a remarkably complex network of kinases and phosphatases that coordinately control Cdc25 and Wee1, thereby precisely regulating the transition into mitosis. Although not all factors that inhibit Cdc25 have been shown to activate Wee1 and vice versa, a number of regulatory modules are clearly shared in common. Thus, studies on either the Cdc25 or Wee1-regulatory arm of the mitotic control pathway should continue to shed light on how both arms are coordinated to smoothly regulate mitotic entry. BioMed Central 2007-05-04 /pmc/articles/PMC1868713/ /pubmed/17480229 http://dx.doi.org/10.1186/1747-1028-2-12 Text en Copyright © 2007 Perry and Kornbluth; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Perry, Jennifer A
Kornbluth, Sally
Cdc25 and Wee1: analogous opposites?
title Cdc25 and Wee1: analogous opposites?
title_full Cdc25 and Wee1: analogous opposites?
title_fullStr Cdc25 and Wee1: analogous opposites?
title_full_unstemmed Cdc25 and Wee1: analogous opposites?
title_short Cdc25 and Wee1: analogous opposites?
title_sort cdc25 and wee1: analogous opposites?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868713/
https://www.ncbi.nlm.nih.gov/pubmed/17480229
http://dx.doi.org/10.1186/1747-1028-2-12
work_keys_str_mv AT perryjennifera cdc25andwee1analogousopposites
AT kornbluthsally cdc25andwee1analogousopposites